We are monitoring the impact of COVID-19 on North America Plasma Fractionation Market Get in touch with us for detailed analysis Know More
Share on

North America Plasma Fractionation Market Research Report – Segmented By Product, Application, End User & Country (the United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVId-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2720
Pages: 145

North America Plasma Fractionation Market Size (2022 to 2027)

The size of the Plasma Fractionation Market in North America was worth USD 7.00 billion in 2022. This value is forecasted to be growing at a CAGR of 8.3% and value USD 10.42 billion by 2027. Increasing the use of immunoglobulins in several therapeutic areas, increasing the aged population, and the rise in prevalence of rare diseases are primarily driving the growth of the North American plasma fractionation market. 

Plasma Fractionation consists of the fractionation of blood into its constituent parts of red cells, white cells, and platelets suspended in plasma. The plasma is studied for deficiencies relating to blood disorders and replaced or supplemented with a cure.

Plasma, which constitutes about 55% of blood by volume, consists of several different proteins numbering into the thousands and other substances like minerals, hormones, etc. There are many therapeutic uses for the proteins present in plasma. For example, Albumin is commonly used to rejuvenate and maintain blood volume after traumatic injury, surgery, and plasma exchange.

Increasing the use of immunoglobulins, antibodies, the rising incidence of immune and bleeding disorders, the growing occurrence of Alpha-1 Antitrypsin deficiency, and the aging population prone to blood-related ailments are key factors driving the market.

However, adversarial reactions to the procedure of plasma fractionation and transfer, high costs of plasma products, and unfavorable reimbursement policies are the main constraints of market growth.

This research report on North America Plasma Fractionation Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Albumin
  • Immunoglobulin
  • Factor VIII
  • Protease Inhibitors

By Application: 

  • Neurology
  • Hematology
  • Rheumatology
  • Pulmonology
  • Immunology

By End User: 

  • Hospitals
  • Clinical Laboratories

By Country: 

  • The United States
  • Canada
  • Rest of North America

Based on the region, the North American plasma fractionation market accounted for a significant chunk of the global share in 2020. The U.S. accounted for a considerable share in the North American market. Swift introduction of new blood-related procedures driven by the increasing incidence of blood disorders due to the growing population age drives the North American plasma fractionation market.

The U.S. Plasma Fractionation Market is estimated to occupy a significant share in the North American market during the forecast period due to technological advancements, favorable reimbursement policies, and a high standard of living that have led to increased life expectancy. The growing geriatric population in the United States is expected to drive the market because aging is considered the top risk factor for developing cardiovascular and neurological diseases in aged people. In the United States, the population age 60 and more numbered 49.2 million in 2016, representing 15.2% of the population, about one in every seven Americans. The increasing number of plasma collection centers across the United States is expected to help the market's growth. According to FDA data in the United States, there are 805 plasma donation centers. The cases of COPD are likely to increase in the United States due to substantial smoking prevalence and geriatric populations. Moreover, according to the American Academy of Allergy, Asthma & Immunology, in 2016, around 8.3% of children in the United States had asthma disease. Asthma is the most common chronic disease found in American children.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North American plasma fractionation market profiled in the report are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fractionation Process         

                                5.1.3 Immunoglobulin   

                                5.1.4 Coagulation Factor Concentrates  

                                5.1.5 Albumin   

                                5.1.6 Protease Inhibitors              

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Neurology               

                                5.2.3 Immunology           

                                5.2.4 Hematology            

                                5.2.5 Critical Care             

                                5.2.6 Pulmonology          

                                5.2.7 Hemato-Oncology               

                                5.2.8 Rheumatology       

                                5.2.9 Other Application 

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

                5.3 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Laboratories            

                                5.4.4 Academic Institutes            

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxalta Incorporated                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 CSL Ltd.                        

                8.3 Grifols S.A                   

                8.4 Octapharma AG                        

                8.5 Kedrion S.p.A                            

                8.6 Bio Products Laboratory                        

                8.7 Sanquin                        

                8.8 China Biologic Products, Inc.                

                8.9 Biotest AG                  

                8.10 Laboratoire Français du Fractionnement et des Biotechnologies                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  2. North America Immunoglobulin Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Coagulation Factor Concentrates Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Albumin Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Protease Inhibitors Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Other Plasma Products Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  8. North America Neurology Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Immunology Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Hematology Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Critical Care Market, By Region, From 2022 - 2027 (USD Million)
  12. North America Pulmonology Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Hemato-oncology Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Rheumatology Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Other Applications Market, By Region, From 2022 - 2027 (USD Million)
  16. North America Plasma Fractionation Market, By By End User, From 2022 - 2027 (USD Million)
  17. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  18. North America Clinical Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Academic Institutes Market, By Region, From 2022 - 2027 (USD Million)
  20. United States Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  21. United States Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  22. United States Plasma Fractionation Market, By By End User, From 2022 - 2027 (USD Million)
  23. Canada Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  24. Canada Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  25. Canada Plasma Fractionation Market, By By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample